Skip to main navigation Skip to search Skip to main content

Innovative signaling inhibition in breast cancer using folate-targeted lipid nanoparticles.

Prize: Fellowship awarded competitively

Description

Gilead GÉNESE, 26592 (2025-2027).
Awarded date2025
Granting OrganisationsGilead Génese

    Fingerprint